About Enavate Sciences
Enavate Sciences is a company based in United States founded in 2022.. Enavate Sciences has raised $300 million across 1 funding round from investors including Patient Square Capital. Enavate Sciences offers products and services including Investment Services. Enavate Sciences operates in a competitive market with competitors including Indegene, Zuellig Pharma, IntegriChain, Fishawack and Clinigen, among others.
- Headquarter United States
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$300 M (USD)
in 1 rounds
-
Latest Funding Round
$300 M (USD), Series D
May 02, 2022
- Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Enavate Sciences
Enavate Sciences offers a comprehensive portfolio of products and services, including Investment Services. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Provides funding and support to life sciences companies for growth.
Unlock access to complete
Unlock access to complete
Funding Insights of Enavate Sciences
Enavate Sciences has successfully raised a total of $300M through 1 strategic funding round. The most recent funding activity was a Series D round of $300 million completed in May 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Series D — $300.0M
-
First Round
First Round
(02 May 2022)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May, 2022 | Amount | Series D - Enavate Sciences | Valuation | Patient Square Capital |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Enavate Sciences
Enavate Sciences has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Patient Square Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Patient Square Capital is focused on health care investments.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Enavate Sciences
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Enavate Sciences
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Enavate Sciences Comparisons
Competitors of Enavate Sciences
Enavate Sciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Indegene, Zuellig Pharma, IntegriChain, Fishawack and Clinigen, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Suite solutions are provided for payers and healthcare providers.
|
|
| domain | founded_year | HQ Location |
Healthcare access in Asia is enhanced by Zuellig Pharma.
|
|
| domain | founded_year | HQ Location |
Inventory, order and customer relationship management solution for life science suppliers.
|
|
| domain | founded_year | HQ Location |
Fully integrated cross-border services are delivered to global pharmaceutical organizations.
|
|
| domain | founded_year | HQ Location |
Specialty medicines are supplied via clinical trials and access programs.
|
|
| domain | founded_year | HQ Location |
Technology-based consultancy and product development services are provided.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Enavate Sciences
Frequently Asked Questions about Enavate Sciences
When was Enavate Sciences founded?
Enavate Sciences was founded in 2022.
Where is Enavate Sciences located?
Enavate Sciences is headquartered in United States.
Who is the current CEO of Enavate Sciences?
James Boylan is the current CEO of Enavate Sciences.
Is Enavate Sciences a funded company?
Enavate Sciences is a funded company, having raised a total of $300M across 1 funding round to date. The company's 1st funding round was a Series D of $300M, raised on May 02, 2022.
What does Enavate Sciences do?
Enavate Sciences was founded in 2022 and is headquartered in the United States. Consulting services are delivered to pharmaceutical and biotechnology firms, focusing on enhancements to drug discovery and development processes. Market assessment services are also offered to evaluate commercial potential and strategic positioning. Operations center on advisory support for lifecycle management in the life sciences sector, with leadership provided by CEO James Boylan.
Who are the top competitors of Enavate Sciences?
Enavate Sciences's top competitors include Indegene, Zuellig Pharma and IntegriChain.
What products or services does Enavate Sciences offer?
Enavate Sciences offers Investment Services.
Who are Enavate Sciences's investors?
Enavate Sciences has 1 investor. Key investors include Patient Square Capital.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.